Treatment of insomnia
The prevalence of insomnia is high in the population of western industrial countries (up to 35 %). Sleep disturbance may consequently lead to an impairment of cognitive functions, mood disturbance and metabolic alterations. Therefore, the confirmation of insomnia and its diagnostic characterization...
Gespeichert in:
| Veröffentlicht in: | Therapeutische Umschau 2009-06, Vol.66 (6), p.441 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 6 |
| container_start_page | 441 |
| container_title | Therapeutische Umschau |
| container_volume | 66 |
| creator | Hemmeter, Ulrich Michael Thum, Andreas |
| description | The prevalence of insomnia is high in the population of western industrial countries (up to 35 %). Sleep disturbance may consequently lead to an impairment of cognitive functions, mood disturbance and metabolic alterations. Therefore, the confirmation of insomnia and its diagnostic characterization is of great importance. Treatment of insomnia is based on its aetiology and intensity. For secondary insomnia treatment of the basic disorder is mandatory. Before the initiation of a symptomatic pharmacological treatment the application of non-pharmacological interventions should be considered. Efficacious pharmacological interventions are non-benzodiazepine hypnotics for a limited time span. If a longer treatment of insomnia is necessary, hypnotic antidepressants and hypnotic neuroleptics (without anti-cholinergic action) can be applied taking the specific side effects into account. Classical benzodiazepines and substances with anti-cholinergic properties should be avoided in particular in long-term treatment and in elderly subjects due to its side effect profile. |
| doi_str_mv | 10.1024/0040-5930.66.6.441 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_19496040</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19496040</sourcerecordid><originalsourceid>FETCH-LOGICAL-p540-3eb8350b0217df4c5b9af10465156ad53a65b78e58d3ec9e166064985bcf3cc63</originalsourceid><addsrcrecordid>eNo9jk2LwkAQRPvgsrrZPXrxIP6BxB6nu80cRXZVEPaSu8xMZiBiYkj04L83sB-nourBowBmCjOFK1oiEqZsNGYimWREagST_3EMb31_HioTyyuMlSEjA5zAtOiCvdWhuS2ucVE1_bVuKvsOL9Fe-vDxmwkUX5_Fdp8ev3eH7eaYtjyYdXC5ZnS4UusykmdnbFRIworFlqytsFvngfNSB2-CEkEhk7PzUXsvOoH5j7a9uzqUp7arats9Tn_39BPZtTii</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Treatment of insomnia</title><source>Hogrefe eContent</source><source>MEDLINE</source><creator>Hemmeter, Ulrich Michael ; Thum, Andreas</creator><creatorcontrib>Hemmeter, Ulrich Michael ; Thum, Andreas</creatorcontrib><description>The prevalence of insomnia is high in the population of western industrial countries (up to 35 %). Sleep disturbance may consequently lead to an impairment of cognitive functions, mood disturbance and metabolic alterations. Therefore, the confirmation of insomnia and its diagnostic characterization is of great importance. Treatment of insomnia is based on its aetiology and intensity. For secondary insomnia treatment of the basic disorder is mandatory. Before the initiation of a symptomatic pharmacological treatment the application of non-pharmacological interventions should be considered. Efficacious pharmacological interventions are non-benzodiazepine hypnotics for a limited time span. If a longer treatment of insomnia is necessary, hypnotic antidepressants and hypnotic neuroleptics (without anti-cholinergic action) can be applied taking the specific side effects into account. Classical benzodiazepines and substances with anti-cholinergic properties should be avoided in particular in long-term treatment and in elderly subjects due to its side effect profile.</description><identifier>ISSN: 0040-5930</identifier><identifier>DOI: 10.1024/0040-5930.66.6.441</identifier><identifier>PMID: 19496040</identifier><language>ger</language><publisher>Switzerland</publisher><subject>Algorithms ; Antidepressive Agents - adverse effects ; Antidepressive Agents - classification ; Antidepressive Agents - therapeutic use ; Behavior Therapy ; Combined Modality Therapy ; Diagnosis, Differential ; Evidence-Based Medicine ; Health Behavior ; Humans ; Hypnotics and Sedatives - adverse effects ; Hypnotics and Sedatives - classification ; Hypnotics and Sedatives - therapeutic use ; Patient Education as Topic ; Relaxation Therapy ; Risk Factors ; Sleep Initiation and Maintenance Disorders - drug therapy ; Sleep Initiation and Maintenance Disorders - etiology</subject><ispartof>Therapeutische Umschau, 2009-06, Vol.66 (6), p.441</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19496040$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hemmeter, Ulrich Michael</creatorcontrib><creatorcontrib>Thum, Andreas</creatorcontrib><title>Treatment of insomnia</title><title>Therapeutische Umschau</title><addtitle>Ther Umsch</addtitle><description>The prevalence of insomnia is high in the population of western industrial countries (up to 35 %). Sleep disturbance may consequently lead to an impairment of cognitive functions, mood disturbance and metabolic alterations. Therefore, the confirmation of insomnia and its diagnostic characterization is of great importance. Treatment of insomnia is based on its aetiology and intensity. For secondary insomnia treatment of the basic disorder is mandatory. Before the initiation of a symptomatic pharmacological treatment the application of non-pharmacological interventions should be considered. Efficacious pharmacological interventions are non-benzodiazepine hypnotics for a limited time span. If a longer treatment of insomnia is necessary, hypnotic antidepressants and hypnotic neuroleptics (without anti-cholinergic action) can be applied taking the specific side effects into account. Classical benzodiazepines and substances with anti-cholinergic properties should be avoided in particular in long-term treatment and in elderly subjects due to its side effect profile.</description><subject>Algorithms</subject><subject>Antidepressive Agents - adverse effects</subject><subject>Antidepressive Agents - classification</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Behavior Therapy</subject><subject>Combined Modality Therapy</subject><subject>Diagnosis, Differential</subject><subject>Evidence-Based Medicine</subject><subject>Health Behavior</subject><subject>Humans</subject><subject>Hypnotics and Sedatives - adverse effects</subject><subject>Hypnotics and Sedatives - classification</subject><subject>Hypnotics and Sedatives - therapeutic use</subject><subject>Patient Education as Topic</subject><subject>Relaxation Therapy</subject><subject>Risk Factors</subject><subject>Sleep Initiation and Maintenance Disorders - drug therapy</subject><subject>Sleep Initiation and Maintenance Disorders - etiology</subject><issn>0040-5930</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9jk2LwkAQRPvgsrrZPXrxIP6BxB6nu80cRXZVEPaSu8xMZiBiYkj04L83sB-nourBowBmCjOFK1oiEqZsNGYimWREagST_3EMb31_HioTyyuMlSEjA5zAtOiCvdWhuS2ucVE1_bVuKvsOL9Fe-vDxmwkUX5_Fdp8ev3eH7eaYtjyYdXC5ZnS4UusykmdnbFRIworFlqytsFvngfNSB2-CEkEhk7PzUXsvOoH5j7a9uzqUp7arats9Tn_39BPZtTii</recordid><startdate>200906</startdate><enddate>200906</enddate><creator>Hemmeter, Ulrich Michael</creator><creator>Thum, Andreas</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200906</creationdate><title>Treatment of insomnia</title><author>Hemmeter, Ulrich Michael ; Thum, Andreas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p540-3eb8350b0217df4c5b9af10465156ad53a65b78e58d3ec9e166064985bcf3cc63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2009</creationdate><topic>Algorithms</topic><topic>Antidepressive Agents - adverse effects</topic><topic>Antidepressive Agents - classification</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Behavior Therapy</topic><topic>Combined Modality Therapy</topic><topic>Diagnosis, Differential</topic><topic>Evidence-Based Medicine</topic><topic>Health Behavior</topic><topic>Humans</topic><topic>Hypnotics and Sedatives - adverse effects</topic><topic>Hypnotics and Sedatives - classification</topic><topic>Hypnotics and Sedatives - therapeutic use</topic><topic>Patient Education as Topic</topic><topic>Relaxation Therapy</topic><topic>Risk Factors</topic><topic>Sleep Initiation and Maintenance Disorders - drug therapy</topic><topic>Sleep Initiation and Maintenance Disorders - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hemmeter, Ulrich Michael</creatorcontrib><creatorcontrib>Thum, Andreas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Therapeutische Umschau</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hemmeter, Ulrich Michael</au><au>Thum, Andreas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of insomnia</atitle><jtitle>Therapeutische Umschau</jtitle><addtitle>Ther Umsch</addtitle><date>2009-06</date><risdate>2009</risdate><volume>66</volume><issue>6</issue><spage>441</spage><pages>441-</pages><issn>0040-5930</issn><abstract>The prevalence of insomnia is high in the population of western industrial countries (up to 35 %). Sleep disturbance may consequently lead to an impairment of cognitive functions, mood disturbance and metabolic alterations. Therefore, the confirmation of insomnia and its diagnostic characterization is of great importance. Treatment of insomnia is based on its aetiology and intensity. For secondary insomnia treatment of the basic disorder is mandatory. Before the initiation of a symptomatic pharmacological treatment the application of non-pharmacological interventions should be considered. Efficacious pharmacological interventions are non-benzodiazepine hypnotics for a limited time span. If a longer treatment of insomnia is necessary, hypnotic antidepressants and hypnotic neuroleptics (without anti-cholinergic action) can be applied taking the specific side effects into account. Classical benzodiazepines and substances with anti-cholinergic properties should be avoided in particular in long-term treatment and in elderly subjects due to its side effect profile.</abstract><cop>Switzerland</cop><pmid>19496040</pmid><doi>10.1024/0040-5930.66.6.441</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0040-5930 |
| ispartof | Therapeutische Umschau, 2009-06, Vol.66 (6), p.441 |
| issn | 0040-5930 |
| language | ger |
| recordid | cdi_pubmed_primary_19496040 |
| source | Hogrefe eContent; MEDLINE |
| subjects | Algorithms Antidepressive Agents - adverse effects Antidepressive Agents - classification Antidepressive Agents - therapeutic use Behavior Therapy Combined Modality Therapy Diagnosis, Differential Evidence-Based Medicine Health Behavior Humans Hypnotics and Sedatives - adverse effects Hypnotics and Sedatives - classification Hypnotics and Sedatives - therapeutic use Patient Education as Topic Relaxation Therapy Risk Factors Sleep Initiation and Maintenance Disorders - drug therapy Sleep Initiation and Maintenance Disorders - etiology |
| title | Treatment of insomnia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T18%3A35%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20insomnia&rft.jtitle=Therapeutische%20Umschau&rft.au=Hemmeter,%20Ulrich%20Michael&rft.date=2009-06&rft.volume=66&rft.issue=6&rft.spage=441&rft.pages=441-&rft.issn=0040-5930&rft_id=info:doi/10.1024/0040-5930.66.6.441&rft_dat=%3Cpubmed%3E19496040%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19496040&rfr_iscdi=true |